Report Detail

Other Global Hospital Infection Therapeutics Market Size, Status and Forecast 2019-2025

  • RnM3462759
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Other

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Hospital Infection Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Antibacterial Drugs
      • 1.4.3 Antiviral Drugs
      • 1.4.4 Antifungal Drugs
    • 1.5 Market by Application
      • 1.5.1 Global Hospital Infection Therapeutics Market Share by Application (2014-2025)
      • 1.5.2 Hospital Acquired Pneumonia
      • 1.5.3 Surgical Site Infections
      • 1.5.4 Urinary Tract Infection
      • 1.5.5 Gastrointestinal Disorders
      • 1.5.6 Bloodstream Infections
      • 1.5.7 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Hospital Infection Therapeutics Market Size
    • 2.2 Hospital Infection Therapeutics Growth Trends by Regions
      • 2.2.1 Hospital Infection Therapeutics Market Size by Regions (2014-2025)
      • 2.2.2 Hospital Infection Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Hospital Infection Therapeutics Market Size by Manufacturers
      • 3.1.1 Global Hospital Infection Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Hospital Infection Therapeutics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Hospital Infection Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Hospital Infection Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Hospital Infection Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Hospital Infection Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Hospital Infection Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Hospital Infection Therapeutics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Hospital Infection Therapeutics Market Size (2014-2019)
    • 5.2 Hospital Infection Therapeutics Key Players in United States
    • 5.3 United States Hospital Infection Therapeutics Market Size by Type
    • 5.4 United States Hospital Infection Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Hospital Infection Therapeutics Market Size (2014-2019)
    • 6.2 Hospital Infection Therapeutics Key Players in Europe
    • 6.3 Europe Hospital Infection Therapeutics Market Size by Type
    • 6.4 Europe Hospital Infection Therapeutics Market Size by Application

    7 China

    • 7.1 China Hospital Infection Therapeutics Market Size (2014-2019)
    • 7.2 Hospital Infection Therapeutics Key Players in China
    • 7.3 China Hospital Infection Therapeutics Market Size by Type
    • 7.4 China Hospital Infection Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Hospital Infection Therapeutics Market Size (2014-2019)
    • 8.2 Hospital Infection Therapeutics Key Players in Japan
    • 8.3 Japan Hospital Infection Therapeutics Market Size by Type
    • 8.4 Japan Hospital Infection Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Hospital Infection Therapeutics Market Size (2014-2019)
    • 9.2 Hospital Infection Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Hospital Infection Therapeutics Market Size by Type
    • 9.4 Southeast Asia Hospital Infection Therapeutics Market Size by Application

    10 India

    • 10.1 India Hospital Infection Therapeutics Market Size (2014-2019)
    • 10.2 Hospital Infection Therapeutics Key Players in India
    • 10.3 India Hospital Infection Therapeutics Market Size by Type
    • 10.4 India Hospital Infection Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Hospital Infection Therapeutics Market Size (2014-2019)
    • 11.2 Hospital Infection Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Hospital Infection Therapeutics Market Size by Type
    • 11.4 Central & South America Hospital Infection Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 Bayer
      • 12.1.1 Bayer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Hospital Infection Therapeutics Introduction
      • 12.1.4 Bayer Revenue in Hospital Infection Therapeutics Business (2014-2019)
      • 12.1.5 Bayer Recent Development
    • 12.2 Johnson & Johnson Services
      • 12.2.1 Johnson & Johnson Services Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Hospital Infection Therapeutics Introduction
      • 12.2.4 Johnson & Johnson Services Revenue in Hospital Infection Therapeutics Business (2014-2019)
      • 12.2.5 Johnson & Johnson Services Recent Development
    • 12.3 Actavis
      • 12.3.1 Actavis Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Hospital Infection Therapeutics Introduction
      • 12.3.4 Actavis Revenue in Hospital Infection Therapeutics Business (2014-2019)
      • 12.3.5 Actavis Recent Development
    • 12.4 Sanofi
      • 12.4.1 Sanofi Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Hospital Infection Therapeutics Introduction
      • 12.4.4 Sanofi Revenue in Hospital Infection Therapeutics Business (2014-2019)
      • 12.4.5 Sanofi Recent Development
    • 12.5 Bristol Myers Squibb Company
      • 12.5.1 Bristol Myers Squibb Company Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Hospital Infection Therapeutics Introduction
      • 12.5.4 Bristol Myers Squibb Company Revenue in Hospital Infection Therapeutics Business (2014-2019)
      • 12.5.5 Bristol Myers Squibb Company Recent Development
    • 12.6 AstraZeneca
      • 12.6.1 AstraZeneca Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Hospital Infection Therapeutics Introduction
      • 12.6.4 AstraZeneca Revenue in Hospital Infection Therapeutics Business (2014-2019)
      • 12.6.5 AstraZeneca Recent Development
    • 12.7 Pfizer
      • 12.7.1 Pfizer Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Hospital Infection Therapeutics Introduction
      • 12.7.4 Pfizer Revenue in Hospital Infection Therapeutics Business (2014-2019)
      • 12.7.5 Pfizer Recent Development
    • 12.8 Merck
      • 12.8.1 Merck Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Hospital Infection Therapeutics Introduction
      • 12.8.4 Merck Revenue in Hospital Infection Therapeutics Business (2014-2019)
      • 12.8.5 Merck Recent Development
    • 12.9 GlaxoSmithkline
      • 12.9.1 GlaxoSmithkline Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Hospital Infection Therapeutics Introduction
      • 12.9.4 GlaxoSmithkline Revenue in Hospital Infection Therapeutics Business (2014-2019)
      • 12.9.5 GlaxoSmithkline Recent Development
    • 12.10 Cubist Pharmaceuticals
      • 12.10.1 Cubist Pharmaceuticals Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Hospital Infection Therapeutics Introduction
      • 12.10.4 Cubist Pharmaceuticals Revenue in Hospital Infection Therapeutics Business (2014-2019)
      • 12.10.5 Cubist Pharmaceuticals Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Hospital-acquired infections, also known as nosocomial infections, are acquired by patients in the hospitals or healthcare facilities. Urinary tract infections, bloodstream infections, surgical-site infections, Clostridium difficile associated diarrhea, and pneumonia are examples of nosocomial infections.
      The hospital infection therapeutics market is increasing at a significant rate, due to high susceptibility of neonatal population in healthcare setting and high occurrence of numerous hospital infections. Increasing incidences of hospital infections, high number of pipeline drug molecules for specific treatment of healthcare associated infections and high unaddressed needs in most of the countries are some of the factors providing ample opportunities for the hospital infection therapeutics market to grow in the coming years.
      North America led the demand for hospital infection therapeutics market in 2017. The high prevalence of nosocomial infections has been identified as the key factor that has been driving the demand for infection therapeutics in North America and is projected to continue to do so throughout the forecast period. Although North America will remain the leading regional market for hospital infection therapeutics, it is Asia Pacific, which will present the most promising growth opportunities to this market in the near future.
      In 2018, the global Hospital Infection Therapeutics market size was 2700 million US$ and it is expected to reach 3840 million US$ by the end of 2025, with a CAGR of 4.5% during 2019-2025.

      This report focuses on the global Hospital Infection Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hospital Infection Therapeutics development in United States, Europe and China.

      The key players covered in this study
      Bayer
      Johnson & Johnson Services
      Actavis
      Sanofi
      Bristol Myers Squibb Company
      AstraZeneca
      Pfizer
      Merck
      GlaxoSmithkline
      Cubist Pharmaceuticals

      Market segment by Type, the product can be split into
      Antibacterial Drugs
      Antiviral Drugs
      Antifungal Drugs

      Market segment by Application, split into
      Hospital Acquired Pneumonia
      Surgical Site Infections
      Urinary Tract Infection
      Gastrointestinal Disorders
      Bloodstream Infections
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Hospital Infection Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Hospital Infection Therapeutics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Hospital Infection Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Hospital Infection Therapeutics . Industry analysis & Market Report on Hospital Infection Therapeutics is a syndicated market report, published as Global Hospital Infection Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Hospital Infection Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,092.70
      4,639.05
      6,185.40
      3,534.29
      5,301.43
      7,068.58
      422,705.40
      634,058.10
      845,410.80
      277,136.34
      415,704.51
      554,272.68
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report